Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

valens int. d.o.o - šķidrums

Latvija - latviešu - Zāļu valsts aģentūra

umedica netherlands b.v., netherlands - ranolazīns - ilgstošās darbības tablete - 375 mg

Latvija - latviešu - Zāļu valsts aģentūra

umedica netherlands b.v., netherlands - ranolazīns - ilgstošās darbības tablete - 500 mg

Latvija - latviešu - Zāļu valsts aģentūra

umedica netherlands b.v., netherlands - ranolazīns - ilgstošās darbības tablete - 750 mg

Latvija - latviešu - Zāļu valsts aģentūra

norameda uab, lithuania - bosentāns - apvalkotā tablete - 62,5 mg

Latvija - latviešu - Zāļu valsts aģentūra

norameda uab, lithuania - bosentāns - apvalkotā tablete - 125 mg

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

krka, d.d., novo mesto - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

ratiopharm gmbh - desloratadine - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistamīna līdzekļi sistēmiskai lietošanai, - desloratadine ratiopharm is indicated in adults for the relief of symptoms associated with:allergic rhinitischronic idiopathic urticaria as initially diagnosed by a physician.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

mylan ireland limited - abiraterona acetāts - prostatas audzēji - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.